Michael Kim, Ph.D.

Chief Business Officer

Michael joined C4 Therapeutics in August of 2017 as Vice President, Business Development and assumed the role of Chief Business Officer in April of 2019. Prior to joining C4 Therapeutics, Michael was in the Business Development group at ARIAD Pharmaceuticals where he was responsible for partnering activities in addition to portfolio strategy and alliance management. Michael started his business career as a strategy consultant with Leerink Swann and Company, and progressed to Corporate Strategy and Business Development roles of increasing responsibility at Alkermes, Vertex Pharmaceuticals and FORUM Pharmaceuticals. He received his post-doctoral training as an NIH NRSA Fellow at Harvard Medical School and holds a Ph.D. in Biomedical Engineering from the University of Rochester.